Shattuck Labs, Inc. (NASDAQ:STTK) Financings

Shattuck Labs, Inc.

Financings

RaiseDate
Public offering of shares of common stock and pre-funded warrants
Update: about US$75M · US$4 a share · Leerink Partners +3
Dealers: Leerink Partners (co-lead), J.P. Morgan (co-lead), Piper Sandler (co-lead), Cantor (co-lead)
Jun 10, 2026
Warrant exercise of common stock warrants
Announced: about US$54.9M
Jun 9, 2026
Private placement of common stock and common stock warrants
Closed: US$103M raised · US$0.8677 a share · Warrants at US$1.0846 · Wedbush & Co., LLC
Dealers: Wedbush & Co., LLC (lead)
Buyers: OrbiMed (led the private placement); Coastlands Capital; Prosight Capital; Adage Capital; Redmile Group; NextBio Capital
Use of proceeds: Fund operations into 2029 and advance SL-325 through clinical milestones, including randomized Phase 2 trials
Aug 26, 2025

Read by 6ix AI from the company's releases